Hypertensive treatment and the risks for the cerebral blood flow.
D000367:Age Factors; D002543:Cerebral Hemorrhage / Q000209:etiology*; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000628:therapy; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000628:therapy*; D002532:Intracranial Aneurysm / Q000209:etiology*; D002537:Intracranial Arteriosclerosis / Q000628:therapy; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use
D004232:Diuretics; D046948:Secologanin Tryptamine Alkaloids; D008750:Methyldopa